Society for Research on Nicotine and Tobacco (SRNT 2019)
SRNT’s Annual Meeting provides an excellent opportunity for attendees of all experience levels to participate in the highest caliber of professional programming devoted to research and practice in the field of nicotine and tobacco research. The Annual Meeting includes an education-packed scientific program that allows more than 1,100 international attendees to stay current with the latest breaking research. This year's meeting will be held February 20-23, 2019, at the Hilton San Francisco in San Francisco, California.
Schedule
21 February
F Zanetti
Systems Toxicology Assessment of Repeated Exposure of Human Organotypic Gingival Cultures to Swedish Snus Extracts and Total Particulate Matter from Cigarette Smoke
21 February
A Kuczaj
Interfacial Dynamics of the Model Pulmonary Surfactant in the Presence of Glycerol/ Propylene Glycol Mixtures
21 February
P Langer
Sociodemographic Characteristics of « Heat-not-Burn » Product Users Comparaed with Cigarette Smokers: First-Year Results of a Repeated Crosssectional Survey Japan
22 February
S Boue
Biomarker discovery for nicotine–containing product assessment can be facilitated by intervals, a platform to share and analyze nonclinical and clinical data.
22 February
Loyse Felber Medlin
A Multicenter, Multiregional Study on Biological and Functional Changes in Healthy Adult Smokers during One Year of Continuous Smoking Abstinence
22 February
C Pater
Cardiovascular Effects Observed When Using the Tobacco Heating System (THS) Compared with Continued Smoking
22 February
N Lama
Exploring Discriminant Capacity of Urinary CEMA as Combustion marker in Tobacco Users, a Population Pharmacokinetic Approach
22 February
E Clerc
Creating a repository for the assessment of tobacco-related behavioral outcomes: A case example
22 February
CT Tran
Decreased Levels of Biomarkers of Exposure in Smokers Switching to Carbon Heated Tobacco Product 1.2: A Randomized, Controlled, Open-Label 90-Day Exposure Study
22 February
A van der Plas
Impact of Switching to a Heat-not-burn Tobacco Product on CYP1A2 Activity: A Review of Four Clinical Studies
22 February
S Fredersdorf
Nicotine Pharmacokinetic and Pharmacodynamic Effects of P4M3 Compared With Subjects’ Own Electronic Cigarette
22 February
M Bosilkovska
Nicotine Pharmacokinetics and Subjective Effects following Use of a Novel Nicotinecontaining Powder Product
22 February
E. F. Afolalu
Psychometric Validationof the Aboutdependence: A fit-forpurpose Instrument to Assess Global Dependence on Tobacco and Nicotine Products
22 February
M Hankins
Test-Retest Reliability of the Lifestyle Questionnaire: Post-hoc Analysis of a Smoking Cessation Study
22 February
E Spies
Differences in Perceived Health Risk of Cigarettes and IQOS by Current Product Use Categories and Intention to Quit: A Cross-Sectional Study in Japan
